Brief: Biovica Resolves On Rights Issue Of SEK 29.2 Mln
10/09/2026 06:31
BRIEF-Biovica Resolves On Rights Issue Of SEK 29.2 Mln Sept 10 (Reuters) - Biovica International BIOVICb.ST:
SAID ON WEDNESDAY RESOLVED TO CARRY OUT SHARE ISSUE OF ABOUT SEK 29.2 MILLION WITH PREFERENTIAL RIGHTS FOR EXISTING SHAREHOLDERS
SUBSCRIPTION PRICE HAS BEEN SET AT SEK 0.30 PER B-SHARE
RIGHTS ISSUE IS CARRIED OUT FOR PURPOSE OF STRENGTHENING WORKING CAPITAL TO CONTINUE COMMERCIALISATION OF DIVITUM TKA IN US AND EXPAND PHARMA SERVICE OFFERING
Source text for Workspace: nMFN2b9R2f
Further company coverage: [BIOVICb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))